Powered by blockchain technology, the little Phil platform is an entirely new way of giving that fixes trust issues with charities using a public ledger, smart contracts and unique digital identities (UDID) to provide givers with the Proof of Need and Proof of Impact required to re-establish trust in giving to charity. Little Phil uses blockchain technology and user experience (UX) designed around a positive psychology framework to allow people to have the oversight, control and emotional connection of a philanthropist, without giving large amounts. People are able to give on their terms through their smartphone and track their giving all the way to the moment it’s received. This will create an engaging experience that makes them genuinely feel the positive impact they have had on their cause. In addition to this, charities will have solutions to their fundraising and exploitation concerns at a much lower cost than they currently incur.

ELONCITY decentralizes our power infrastructure into millions of self sufficient microgrids. Locally produced energy is available 24/7 and directly competitive to utilities. Energy price becomes transparent to all. People use Eloncity's open technologies to make electricity virtually free so that we can electrify the world with clean energy.

Newcater is the e-commerce platform for unique and eco-friendly products with a number of apps and solutions supporting payments, delivery and community connectivity. In Newcater Ecosystem, every user can interact, swap, share knowledge and skills, contribute ideas and receive feedbacks, which create a circle of connections, support, sharing, shopping and income generation.

SID (Share Internet Data) is a peer-to-multi-peer decentralized internet sharing system that allows sharing internet from one person's smartphone to another nearby in an automated manner. One of our key missions through the SID project : “To lift as many people as possible out of poverty by means of giving the less fortunate a way to access the Internet”. Certain users will be able to get free Internet access by obtaining tokens in exchange of consuming advertising. Such obtained tokens can then be used to consume internet megabytes from other nearby Users in exchange for tokens OR Users will simply trade some of their tokens directly with other SID Users. Those trades will be done simply through a secured blockchain, on a public exchange to ensure full transparency with the control of the tokens and the control of sharing internet or not fully decentralized, meaning solely under end-user’s control through their post ITO (Initial Token Offering) token Wallet inside the SID App.

At its core, Nice 1 is a blockchain game development platform. When using Nice 1, a game developer can raise funds from public and private supporters. However, Nice 1 goes further than just mere fundraising. The Nice 1 blockchain provides users with access to an SDK library (and documentation) for Unreal Engine & Unity. Nice 1 is striving to create state-of-the-art gaming services for streamers and esports enthusiasts. Non-game developers can earn and support gamers and developers, by helping support the Nice 1 blockchain network. The primary goal of Nice 1, is to promote innovation in gaming worldwide. However, in the process, Nice 1 is also striving to tackle increasing censorship in gaming.

Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.